TherapeuticsMD
TXMD
TXMD
56 hedge funds and large institutions have $362M invested in TherapeuticsMD in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+3
Holders Change %
+5.66%
% of All Funds
1.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
25
Reduced
10
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$22.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.61M |
| 3 |
VM
VHCP Management
New York
|
+$4.41M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.98M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.57M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$25.4M |
| 2 |
DM
Deerfield Management
New York
|
-$3.66M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.02M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.22M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$389K |
